A Randomized Controlled Trial Comparing Zileuton With Theophylline in Moderate Asthma
Author(s) -
Howard J. Schwartz,
Thomas L. Petty,
Louise M. Dubé,
Linda J. Swanson,
John F. Lancaster
Publication year - 1998
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.158.2.141
Subject(s) - zileuton , medicine , theophylline , asthma , placebo , anesthesia , bronchodilator , spirometry , crossover study , randomized controlled trial , arachidonic acid , arachidonate 5 lipoxygenase , chemistry , biochemistry , alternative medicine , pathology , enzyme
Zileuton, a leukotriene pathway inhibitor, was compared with slowly absorbed theophylline in a randomized, double-blind study of patients with chronic asthma. The primary efficacy measure was improvement in forced expiratory volume in 1 second (FEV1).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom